Abstract
The treatment of atrial fibrillation (AF) remains challenging in everyday practice. Even with the introduction of catheter ablation, decision-making about the type of therapy has become more complex. The recently published guidelines of the American College of Cardiology, American Heart Association, and the European Society of Cardiology clearly show the therapeutic approaches for the different types of AF (Fig. 1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fuster V, Ryden LE, Cannom DS et al (2006) 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:700–752
Feinberg WM, Blackshear JL, Laupacis A et al (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469–473
Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271:840–844
Kannel WB, Wolf PA, Benjamin EJ et al (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9N
Krahn AD, Manfreda J, Tate RB et al (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Cardiol 98:476–484
Benjamin EJ, Wolf PA, D’Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952
Lüeritz B, Jung W (2000) Quality of life in patients with atrial fibrillation. Arch Intern Med 160:1749–1757
Wyse DG (2000) The AFFIRM trial: main trial and substudies — what can we expect? J Interv Card Electrophysiol 4:171–176
Jung W, Lüeritz B (1998) Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol 9(Suppl 8):S177–S186
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this paper
Cite this paper
Lüeritz, B. (2007). Anti-arrhythmic Drugs in Atrial Fibrillation: Historical Perspectives and New Developments. In: Gulizia, M.M. (eds) Current News in Cardiology. Springer, Milano. https://doi.org/10.1007/978-88-470-0636-2_1
Download citation
DOI: https://doi.org/10.1007/978-88-470-0636-2_1
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0635-5
Online ISBN: 978-88-470-0636-2
eBook Packages: MedicineMedicine (R0)